152 related articles for article (PubMed ID: 17805016)
1. Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.
Lemeta S; Jarmalaite S; Pylkkänen L; Böhling T; Husgafvel-Pursiainen K
J Neuropathol Exp Neurol; 2007 Sep; 66(9):860-7. PubMed ID: 17805016
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss of heterozygosity at 6q in pheochromocytoma.
Lemeta S; Salmenkivi K; Pylkkänen L; Sainio M; Saarikoski ST; Arola J; Heikkilä P; Haglund C; Husgafvel-Pursiainen K; Böhling T
Hum Pathol; 2006 Jun; 37(6):749-54. PubMed ID: 16733217
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
Jarmalaite S; Laurinaviciene A; Tverkuviene J; Kalinauskaite N; Petroska D; Böhling T; Husgafvel-Pursiainen K
Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
[TBL] [Abstract][Full Text] [Related]
4. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
[TBL] [Abstract][Full Text] [Related]
6. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
Valleley EM; Cordery SF; Bonthron DT
Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
[TBL] [Abstract][Full Text] [Related]
10. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
11. Zac1 functions through TGFbetaII to negatively regulate cell number in the developing retina.
Ma L; Cantrup R; Varrault A; Colak D; Klenin N; Götz M; McFarlane S; Journot L; Schuurmans C
Neural Dev; 2007 Jun; 2():11. PubMed ID: 17559664
[TBL] [Abstract][Full Text] [Related]
12. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
13. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
16. Recurrent (nonfamilial) hemangioblastomas involving spinal nerve roots: case report.
Raghavan R; Krumerman J; Rushing EJ; White CL; Chason DP; Watson ML; Coimbra C
Neurosurgery; 2000 Dec; 47(6):1443-8. PubMed ID: 11126917
[TBL] [Abstract][Full Text] [Related]
17. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
[TBL] [Abstract][Full Text] [Related]
18. Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region.
Pylkkänen L; Sainio M; Ollikainen T; Mattson K; Nordling S; Carpén O; Linnainmaa K; Husgafvel-Pursiainen K
Oncol Rep; 2002; 9(5):955-9. PubMed ID: 12168054
[TBL] [Abstract][Full Text] [Related]
19. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.
Midorikawa Y; Yamamoto S; Ishikawa S; Kamimura N; Igarashi H; Sugimura H; Makuuchi M; Aburatani H
Oncogene; 2006 Sep; 25(40):5581-90. PubMed ID: 16785998
[TBL] [Abstract][Full Text] [Related]
20. Oocyte growth-dependent progression of maternal imprinting in mice.
Hiura H; Obata Y; Komiyama J; Shirai M; Kono T
Genes Cells; 2006 Apr; 11(4):353-61. PubMed ID: 16611239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
